Inhibrx Biosciences Inc 뉴스 - INBX | 주식 나스닥 | ADVFN

다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Inhibrx Biosciences Inc (INBX)
Inhibrx Biosciences Inc (INBX) 뉴스

Inhibrx Biosciences Inc (INBX)

12.49

-0.07

(-0.56%)

마감 25 2월 6:00AM

12.49

0.01

(0.08%)

시간외 거래: 7:25AM

개인 투자자를 위한 전문가급 도구.

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Inhibrx Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

Inhibrx Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights PR Newswire SAN DIEGO...

Form 8-K - Current report

Inhibrx Announces Preliminary Data from the Phase 1 Trial of INBRX-109 for the Treatment of Ewing Sarcoma

Inhibrx Announces Preliminary Data from the Phase 1 Trial of INBRX-109 for the Treatment of Ewing Sarcoma PR...

Inhibrx Announces Participation in Upcoming Scientific Conferences

Inhibrx Announces Participation in Upcoming Scientific Conferences PR Newswire SAN DIEGO, Oct. 18, 2023 SAN...

Form 8-K - Current report

Inhibrx Retains Rights to INBRX-101 for the Treatment of Alpha-1 Antitrypsin Deficiency Outside of the United States and Canada

Inhibrx Retains Rights to INBRX-101 for the Treatment of Alpha-1 Antitrypsin Deficiency Outside of the United...

Form D - Notice of Exempt Offering of Securities

Form 8-K - Current report

Inhibrx Announces $200 Million Private Placement Financing

Inhibrx Announces $200 Million Private Placement Financing PR Newswire SAN DIEGO, Aug. 29, 2023 SAN DIEGO...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Inhibrx Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights

Inhibrx Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights PR Newswire SAN DIEGO...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

2
3
4
다음

Monksdream

Monksdream 4 월 전

Monksdream

Monksdream 5 월 전

Monksdream

Monksdream 6 월 전

Monksdream

Monksdream 11 월 전

TrendTrade2016

TrendTrade2016 2 년 전

heres the dolla...boom!!

TrendTrade2016

TrendTrade2016 2 년 전

INBX DOLLA RUMMER IN PROCESS

TrendTrade2016

TrendTrade2016 2 년 전

INBX...PRE MARKET VOL

Jaydixson1

Jaydixson1 2 년 전

Seems to be dropping

make it happen

make it happen 2 년 전

Numbers do not make sense. They need to raise so much to keep the Phases going. So much debt and money burn with worse quarters and barley any revs. Not bashing it's just what it is. 1,000's of percent's negative on profit. Revenue $0.18 Book Value -$0.12. Also imo this volume isn't sustainable 9 times normal as of now

Profitability
Profit Margin 0.00%
Operating Margin -1,448.76%

Management Effectiveness
Return on Assets -37.98%
Return on Equity -562.25%

Income Statement
Revenue 7.03M
Revenue Per Share 0.18
Quarterly Revenue Growth (yoy) -25.50%
Gross Profit -64.21M
EBITDA -100.6M
Net Income Avi to Common -110.75M
Diluted EPS -2.44

Balance Sheet
Total Debt 175.7M
Book Value Per Share -0.13

Cash Flow Statement
Operating Cash Flow -90.16M
Levered Free Cash Flow -46.31M

Inhibrx Biosciences

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관